Toceranib phosphate in the management of canine insulinoma: A retrospective multicentre study of 30 cases (2009–2019)

BACKGROUND: Insulinomas are the most common tumour of the endocrine pancreas in dogs. These malignant tumours have a high metastatic rate and limited chemotherapeutic options. The multi‐receptor tyrosine kinase inhibitor sunitinib malate has benefit in the treatment of metastatic insulinoma in peopl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheppard‐Olivares, Sabina, Bello, Nora M., Johannes, Chad M., Hocker, Samuel E., Biller, Barbara, Husbands, Brian, Snyder, Elizabeth, McMillan, Mattison, McKee, Talon, Wouda, Raelene M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776903/
https://www.ncbi.nlm.nih.gov/pubmed/35079406
http://dx.doi.org/10.1002/vro2.27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776903/
https://www.ncbi.nlm.nih.gov/pubmed/35079406
http://dx.doi.org/10.1002/vro2.27

Ejemplares similares